First volunteer dosed in intran asal COVID-19 vaccine clinical trial
Open Orphan PLC (ORPH.L) First volunteer dosed in COVID-19 clinical trial
Charting Multibaggers, Bulletin Board Heroes, Sunday 10th January 2020
Zak Mir highlights some of the most followed stocks on the small-cap and gives an overview in this video charting update on why they joined that special group of “Multibaggers”
Open Orphan PLC (ORPH.L) Contract renewal with top-3 pharmaceutical client
Open Orphan plc (AIM: ORPH), a rapidly growing specialist pharmaceutical services CRO and a world leader in vaccine and antiviral testing using human challenge clinical trials, announces a further contract
Weekend Edition, Bulletin Board Heroes, Sunday 3rd January 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Charting Multibaggers stocks on the small-cap’s over the course of 2020
Zak Mir highlights some of the most followed stocks on the small-cap over the course of 2020 listed on the London market and gives an overview in this video charting
Open Orphan PLC (ORPH.L) Rule 19.6(c) Confirmation
RULE 19.6(c) CONFIRMATION WITH RESPECT TO STATED POST-OFFER INTENTIONS WITH REGARD TO HVIVO PLC
Top Twenty, The Stocks of the Year For 2020
The Christmas season used to have a couple of great standout events, apart from the Queen’s Speech and the New Year’s Honours List. The other two were Top of the
Charting Multibaggers video update, Monday 28th December 2020
Zak Mir highlights some of the most followed stocks on the small-cap over the course of 2020 listed on the London market and gives an overview in this video charting
Top Twenty, The Stocks of the Year For 2020
The Christmas season used to have a couple of great standout events, apart from the Queen’s Speech and the New Year’s Honours List. The other two were Top of the
Open Orphan PLC (ORPH.L) Successful completion of toxicology study
Successful completion of PrEP Biopharm Toxicology study for respiratory ‘viral mimic’
Open Orphan PLC (ORPH.L) Contract renewal with top-3 pharmaceutical client
Successful extension of contract underpins 2021 revenue growth expectations
